HUTCHMED Highlights Data to be Presented at AACR Congress 2024

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 -- HUTCHMED Limited today announces that new and updated data from several studies of compounds discovered by HUTCHMED will...

Related Keywords

Veneto ,Italy ,Hong Kong ,Texas ,United States ,Beijing ,China ,Chongqing ,National Taiwan University Hospital ,T Ai Pei ,Taiwan ,Huazhong ,Hubei ,Tianjin ,Taipei ,Shanghai ,Ming Lu ,Hunan ,Nanjing ,Jiangsu ,Guangzhou ,Guangdong ,San Diego ,California ,Peking ,Tongji ,Sichuan ,Chong Ma ,Guangxi ,National Taiwan University ,Lin Shen ,Wuhan ,Min Cheng ,T Ai Chung ,Chinese ,American ,Jihui Hao ,Xianwen Yang ,Zhou Yi ,Susheng Shi ,Guanghai Dai ,Atholl Tweedie ,Zhenyu Lin ,Stefano Lonardi ,Yan Xu ,Yaru Wen ,James Chih Hsin Yang ,Daphne Zhang ,Tao Zhang ,Ras Gtpase ,Yanfang Zheng ,Jun Zhang ,Xiaolin Li ,Ben Atwell Alex Shaw ,Linkedin ,Cancer Hospital Institute Of Guangzhou Medical University ,Huazhong University Of Science ,Veneto Institute Of Oncology ,First Affiliated Hospital Of Nanjing Medical University ,China Limited ,Cancer Center ,University Of Texas Md Anderson Cancer Center ,University Cancer Hospital ,National Taiwan University Cancer Centre ,Exchange Commission ,Wuhan Union Hospital ,Union Hospital Tongji Medical College ,American Association Of Cancer Research ,Nasdaq ,Stock Exchange Of Hong Kong ,First Affiliated Hospital Of Chongqing Medical University ,Tianjin Medical University Cancer Institute ,Cancer Hospital Chinese Academy Of Medical Sciences ,American Association ,Cancer Research ,Annual Meeting ,Drug Response ,Drug Conjugates ,Bispectific Antibodies ,Signaling Components ,Therapeutic Targets ,Syk Inhibitor ,Phasei Clinical Trials ,Veneto Institute ,Chih Hsin Yang ,First Affiliated Hospital ,Nanjing Medical University ,Affiliated Cancer Hospital ,Guangzhou Medical University ,Biliary Tract Cancer ,Dual Role ,Tumor Suppression ,Song Gao ,Underlying Mechanisms ,Surufatinib Combined ,Huazhong University ,Real World Data ,Cancer Hospital Chinese Academy ,Medical Sciences ,Therapeutic Outcomes ,Chongqing Medical University ,Epidemiological Methodology ,Peking University Cancer Hospital ,Securities Litigation Reform Act ,Stock Exchange ,Hong Kong Limited ,Alex Shaw ,